Skip to main content
Top
Published in: Endocrine 3/2015

01-12-2015 | Original Article

Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men

Authors: Jae-Hong Ryoo, Sung Keun Park, Sungmin Ye, Joong-Myung Choi, Chang-Mo Oh, Sun Yong Kim, Ju-Young Shin, Jai Hyung Park, Hyun Pyo Hong, Taeg Su Ko

Published in: Endocrine | Issue 3/2015

Login to get access

Abstract

Although obesity is clearly identified as a risk factor for diabetes, the relationship between diabetes and metabolically healthy status of obesity is less clear. This study was aimed to evaluate the incidental risk of diabetes according to metabolically healthy status of obesity. 31,834 Korean men without diabetes categorized into six groups according to their metabolically healthy status stratified by degree of obesity were followed up for 5 years: metabolically healthy normal weight (MH-NW), metabolically healthy overweight (MH-OW), metabolically healthy obese (MHO), metabolically unhealthy normal weight (MU-NW), metabolically unhealthy overweight (MU-OW), and metabolically unhealthy obese (MUO). Cox proportional hazards analysis was used to measure the risk for diabetes according to their categories. While overall incidence was 9.0 %, incidence of diabetes was in proportion to the degree of obesity and metabolically healthy status (MH-NW: 6.3 %, MH-OW: 7.5 %, MHO: 9.2 %, MU-NW: 11.8 %, MU-OW: 14.9 %, MUO: 20.1 %). When MH-NW was set as reference, the adjusted HRs (95 % CI) for diabetes of the MH-OW, MHO, MU-NW, MU-OW, MUO compared to MH-NW were 1.18 (1.06–1.32), 1.58 (1.03–2.41), 1.81 (1.61–2.04), 2.36 (2.11–2.63), and 3.47 (2.84–4.24), respectively. In conclusion, risk for diabetes was in proportion to the degree of obesity in both metabolically healthy and unhealthy group. Metabolically healthy status was more significant determinant for incident diabetes than obesity itself.
Literature
1.
go back to reference N. Stefan, H.U. Häring, F.B. Hu, M.B. Schulze, Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1, 152–162 (2013)CrossRefPubMed N. Stefan, H.U. Häring, F.B. Hu, M.B. Schulze, Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1, 152–162 (2013)CrossRefPubMed
2.
go back to reference A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales, J.S. Marks, Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 289, 76–79 (2003)CrossRefPubMed A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales, J.S. Marks, Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 289, 76–79 (2003)CrossRefPubMed
3.
go back to reference G.M. Hinnouho, S. Czernichow, A. Dugravot, G.D. Batty, M. Kivimaki, A. Singh-Manoux, Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 36, 2294–2300 (2013)PubMedCentralCrossRefPubMed G.M. Hinnouho, S. Czernichow, A. Dugravot, G.D. Batty, M. Kivimaki, A. Singh-Manoux, Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 36, 2294–2300 (2013)PubMedCentralCrossRefPubMed
4.
go back to reference Y. Chang, B.K. Kim, K.E. Yun, J. Cho, Y. Zhang, S. Rampal, D. Zhao, H.S. Jung, Y. Choi, J. Ahn, J.A. Lima, H. Shin, E. Guallar, S. Ryu, Metabolically-healthy obesity and coronary artery calcification. J. Am. Coll. Cardiol. 63, 2679–2686 (2014)CrossRefPubMed Y. Chang, B.K. Kim, K.E. Yun, J. Cho, Y. Zhang, S. Rampal, D. Zhao, H.S. Jung, Y. Choi, J. Ahn, J.A. Lima, H. Shin, E. Guallar, S. Ryu, Metabolically-healthy obesity and coronary artery calcification. J. Am. Coll. Cardiol. 63, 2679–2686 (2014)CrossRefPubMed
6.
go back to reference M. Hamer, G.D. Batty, M. Kivimaki, Risk of future depression in people who are obese but metabolically healthy: the english longitudinal study of ageing. Mol. Psychiatry 17, 940–945 (2012)PubMedCentralCrossRefPubMed M. Hamer, G.D. Batty, M. Kivimaki, Risk of future depression in people who are obese but metabolically healthy: the english longitudinal study of ageing. Mol. Psychiatry 17, 940–945 (2012)PubMedCentralCrossRefPubMed
7.
go back to reference J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan, R.B. D’Agostino, Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 91, 2906–2912 (2006)CrossRefPubMed J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan, R.B. D’Agostino, Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 91, 2906–2912 (2006)CrossRefPubMed
8.
go back to reference S.L. Appleton, C.J. Seaborn, R. Visvanathan, C.L. Hill, T.K. Gill, A.W. Taylor, R.J. Adams, North West Adelaide Health Study Team, Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype a cohort study. Diabetes Care 36, 2388–2394 (2013)PubMedCentralCrossRefPubMed S.L. Appleton, C.J. Seaborn, R. Visvanathan, C.L. Hill, T.K. Gill, A.W. Taylor, R.J. Adams, North West Adelaide Health Study Team, Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype a cohort study. Diabetes Care 36, 2388–2394 (2013)PubMedCentralCrossRefPubMed
9.
go back to reference F. Hadaegh, M. Bozorgmanesh, M. Safarkhani, D. Khalili, F. Azizi, Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome? BMC Public Health 11, 1–9 (2011)CrossRef F. Hadaegh, M. Bozorgmanesh, M. Safarkhani, D. Khalili, F. Azizi, Predictability of body mass index for diabetes: affected by the presence of metabolic syndrome? BMC Public Health 11, 1–9 (2011)CrossRef
10.
go back to reference F. Soriguer, C. Gutiérrez-Repiso, E. Rubio-Martín, E. García-Fuentes, M.C. Almaraz, N. Colomo, I. Esteva de Antonio, M.S. de Adana, F.J. Chaves, S. Morcillo, S. Valdés, G. Rojo-Martínez, Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J. Clin. Endocrinol. Metab. 98, 2318–2325 (2013)CrossRefPubMed F. Soriguer, C. Gutiérrez-Repiso, E. Rubio-Martín, E. García-Fuentes, M.C. Almaraz, N. Colomo, I. Esteva de Antonio, M.S. de Adana, F.J. Chaves, S. Morcillo, S. Valdés, G. Rojo-Martínez, Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J. Clin. Endocrinol. Metab. 98, 2318–2325 (2013)CrossRefPubMed
11.
go back to reference D. Luo, F. Liu, X. Li, D. Yin, Z. Lin, H. Liu, X. Hou, C. Wang, W. Jia, Comparison of the effect of ‘metabolically healthy but obese’ and ‘metabolically abnormal but not obese’ phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine 49, 130–138 (2015)CrossRefPubMed D. Luo, F. Liu, X. Li, D. Yin, Z. Lin, H. Liu, X. Hou, C. Wang, W. Jia, Comparison of the effect of ‘metabolically healthy but obese’ and ‘metabolically abnormal but not obese’ phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine 49, 130–138 (2015)CrossRefPubMed
12.
go back to reference S.K. Park, M.H. Seo, H.C. Shin, J.H. Ryoo, Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. Hepatology 57, 1378–1383 (2013)CrossRefPubMed S.K. Park, M.H. Seo, H.C. Shin, J.H. Ryoo, Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. Hepatology 57, 1378–1383 (2013)CrossRefPubMed
13.
14.
go back to reference D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRefPubMed D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985)CrossRefPubMed
15.
go back to reference A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, Lente F. Van, T. Greene, J. Coresh, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009)PubMedCentralCrossRefPubMed A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, Lente F. Van, T. Greene, J. Coresh, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration), A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009)PubMedCentralCrossRefPubMed
16.
go back to reference S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, M. Hurley, K.D. Mullen, J.N. Cooper, M.J. Sheridan, The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745–750 (2002)CrossRefPubMed S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, M. Hurley, K.D. Mullen, J.N. Cooper, M.J. Sheridan, The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745–750 (2002)CrossRefPubMed
17.
go back to reference S.H. Saverymuttu, A.E. Joseph, J.D. Maxwell, Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br. Med. J. (Clin Res Ed) 292, 13–15 (1986)CrossRef S.H. Saverymuttu, A.E. Joseph, J.D. Maxwell, Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br. Med. J. (Clin Res Ed) 292, 13–15 (1986)CrossRef
18.
go back to reference R. Hernaez, M. Lazo, S. Bonekamp, I. Kamel, F.L. Brancati, E. Guallar, J.M. Clark, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54, 1982–1990 (2011)CrossRef R. Hernaez, M. Lazo, S. Bonekamp, I. Kamel, F.L. Brancati, E. Guallar, J.M. Clark, Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54, 1982–1990 (2011)CrossRef
19.
go back to reference Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i–xii:1–253 (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i–xii:1–253 (2000)
20.
go back to reference R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, M.R. Sowers, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med. 168, 1617–1624 (2008)CrossRefPubMed R.P. Wildman, P. Muntner, K. Reynolds, A.P. McGinn, S. Rajpathak, J. Wylie-Rosett, M.R. Sowers, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med. 168, 1617–1624 (2008)CrossRefPubMed
21.
go back to reference K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity, Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Force on epidemiology and prevention; National heart, Lung, and blood Institute; American heart association; World heart Federation; International atherosclerosis Society; and International association for the study of obesity. Circulation 120, 1640–1645 (2009)CrossRefPubMed K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity, Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Force on epidemiology and prevention; National heart, Lung, and blood Institute; American heart association; World heart Federation; International atherosclerosis Society; and International association for the study of obesity. Circulation 120, 1640–1645 (2009)CrossRefPubMed
22.
23.
go back to reference L.C. Hwang, C.H. Bai, C.A. Sun, C.J. Chen, Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac. J. Clin. Nutr. 21, 227–233 (2012)PubMed L.C. Hwang, C.H. Bai, C.A. Sun, C.J. Chen, Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac. J. Clin. Nutr. 21, 227–233 (2012)PubMed
24.
go back to reference E.-J. Rhee, M.K. Lee, J.D. Kim, W.S. Jeon, J.C. Bae, S.E. Park, C.Y. Park, K.W. Oh, S.W. Park, W.Y. Lee, Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study. PLoS One 9, e98369 (2014)PubMedCentralCrossRefPubMed E.-J. Rhee, M.K. Lee, J.D. Kim, W.S. Jeon, J.C. Bae, S.E. Park, C.Y. Park, K.W. Oh, S.W. Park, W.Y. Lee, Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study. PLoS One 9, e98369 (2014)PubMedCentralCrossRefPubMed
25.
go back to reference A. Mor, E. Svensson, J. Rungby, S.P. Ulrichsen, K. Berencsi, J.S. Nielsen, J.V. Stidsen, S. Friborg, I. Brandslund, J.S. Christiansen, H. Beck-Nielsen, H.T. Sørensen, R.W. Thomsen, Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study. Diabetes Metab. Res. Rev. 30, 707–715 (2014)CrossRefPubMed A. Mor, E. Svensson, J. Rungby, S.P. Ulrichsen, K. Berencsi, J.S. Nielsen, J.V. Stidsen, S. Friborg, I. Brandslund, J.S. Christiansen, H. Beck-Nielsen, H.T. Sørensen, R.W. Thomsen, Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study. Diabetes Metab. Res. Rev. 30, 707–715 (2014)CrossRefPubMed
26.
go back to reference N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, H.U. Häring, Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168, 1609–1616 (2008)CrossRefPubMed N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, H.U. Häring, Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168, 1609–1616 (2008)CrossRefPubMed
27.
go back to reference Y. Chang, H.S. Jung, K.E. Yun, J. Cho, Y.K. Cho, S. Ryu, Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am. J. Gastroenterol. 108, 1861–1868 (2013)CrossRefPubMed Y. Chang, H.S. Jung, K.E. Yun, J. Cho, Y.K. Cho, S. Ryu, Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am. J. Gastroenterol. 108, 1861–1868 (2013)CrossRefPubMed
28.
go back to reference K.C. Sung, S.H. Wild, C.D. Byrne, Resolution of fatty liver and risk of incident diabetes. J. Clin. Endocrinol. Metab. 98, 3637–3643 (2013)CrossRefPubMed K.C. Sung, S.H. Wild, C.D. Byrne, Resolution of fatty liver and risk of incident diabetes. J. Clin. Endocrinol. Metab. 98, 3637–3643 (2013)CrossRefPubMed
29.
go back to reference M. Hamer, E. Stamatakis, Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 97, 2482–2488 (2012)PubMedCentralCrossRefPubMed M. Hamer, E. Stamatakis, Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 97, 2482–2488 (2012)PubMedCentralCrossRefPubMed
30.
go back to reference C.M. Durward, T.J. Hartman, S.M. Nickols-Richardson, All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J. Obes. 2012, 460321 (2012)PubMedCentralCrossRefPubMed C.M. Durward, T.J. Hartman, S.M. Nickols-Richardson, All-cause mortality risk of metabolically healthy obese individuals in NHANES III. J. Obes. 2012, 460321 (2012)PubMedCentralCrossRefPubMed
31.
go back to reference K. Aung, C. Lorenzo, M.A. Hinojosa, S.M. Haffner, Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J. Clin. Endocrinol. Metab. 99, 462–468 (2014)PubMedCentralCrossRefPubMed K. Aung, C. Lorenzo, M.A. Hinojosa, S.M. Haffner, Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J. Clin. Endocrinol. Metab. 99, 462–468 (2014)PubMedCentralCrossRefPubMed
32.
go back to reference C.K. Kramer, B. Zinman, R. Retnakaran, Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann. Intern. Med. 159, 758–769 (2013)CrossRefPubMed C.K. Kramer, B. Zinman, R. Retnakaran, Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann. Intern. Med. 159, 758–769 (2013)CrossRefPubMed
33.
go back to reference J.A. Bell, M. Kivimaki, M. Hamer, Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes. Rev. 15, 504–515 (2014)PubMedCentralCrossRefPubMed J.A. Bell, M. Kivimaki, M. Hamer, Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes. Rev. 15, 504–515 (2014)PubMedCentralCrossRefPubMed
34.
go back to reference B.J. Arsenault, M. Côté, A. Cartier, I. Lemieux, J.P. Després, R. Ross, C.P. Earnest, S.N. Blair, T.S. Church, Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis 207, 530–533 (2009)PubMedCentralCrossRefPubMed B.J. Arsenault, M. Côté, A. Cartier, I. Lemieux, J.P. Després, R. Ross, C.P. Earnest, S.N. Blair, T.S. Church, Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis 207, 530–533 (2009)PubMedCentralCrossRefPubMed
35.
go back to reference M.J. Shin, Y.J. Hyun, O.Y. Kim, J.Y. Kim, Y. Jang, J.H. Lee, Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int. J. Obes. (Lond) 30, 1529–1534 (2006)CrossRef M.J. Shin, Y.J. Hyun, O.Y. Kim, J.Y. Kim, Y. Jang, J.H. Lee, Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int. J. Obes. (Lond) 30, 1529–1534 (2006)CrossRef
36.
go back to reference K. Kantartzis, J. Machann, F. Schick, K. Rittig, F. Machicao, A. Fritsche, H.U. Häring, N. Stefan, Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 54, 864–868 (2011)CrossRefPubMed K. Kantartzis, J. Machann, F. Schick, K. Rittig, F. Machicao, A. Fritsche, H.U. Häring, N. Stefan, Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 54, 864–868 (2011)CrossRefPubMed
37.
go back to reference A. Koster, S. Stenholm, D.E. Alley, L.J. Kim, E.M. Simonsick, A.M. Kanaya, M. Visser, D.K. Houston, B.J. Nicklas, F.A. Tylavsky, S. Satterfield, B.H. Goodpaster, L. Ferrucci, T.B. Harris, Health ABC Study: body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 18, 2354–2361 (2010)CrossRef A. Koster, S. Stenholm, D.E. Alley, L.J. Kim, E.M. Simonsick, A.M. Kanaya, M. Visser, D.K. Houston, B.J. Nicklas, F.A. Tylavsky, S. Satterfield, B.H. Goodpaster, L. Ferrucci, T.B. Harris, Health ABC Study: body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 18, 2354–2361 (2010)CrossRef
38.
go back to reference S.M. Camhi, P.T. Katzmarzyk, Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int. J. Obes. (Lond) 38, 42–1145 (2014)CrossRef S.M. Camhi, P.T. Katzmarzyk, Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int. J. Obes. (Lond) 38, 42–1145 (2014)CrossRef
Metadata
Title
Estimation of risk for diabetes according to the metabolically healthy status stratified by degree of obesity in Korean men
Authors
Jae-Hong Ryoo
Sung Keun Park
Sungmin Ye
Joong-Myung Choi
Chang-Mo Oh
Sun Yong Kim
Ju-Young Shin
Jai Hyung Park
Hyun Pyo Hong
Taeg Su Ko
Publication date
01-12-2015
Publisher
Springer US
Published in
Endocrine / Issue 3/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0635-5

Other articles of this Issue 3/2015

Endocrine 3/2015 Go to the issue